North Korea refuses to accept 3 million doses of China’s Covid-19 vaccine

In this undated photo provided by the North Korean government on July 30, 2021, North Korean leader Kim Jong-un participates in a seminar for commanders and political officials of the Korean People’s Army in Pyongyang, North Korea.

In this undated photo provided by the North Korean government on July 30, 2021, North Korean leader Kim Jong-un participates in a seminar for commanders and political officials of the Korean People’s Army in Pyongyang, North Korea.
Photo: Korea Central News Agency/Korea News Agency (Associated Press)

According to the US state-funded broadcaster, the North Korean government rejected nearly 3 million doses of China’s covid-19 vaccine Kexing this week, claiming that they should be sent to countries that are fighting the coronavirus pandemic. Voice of AmericaSince the beginning of the pandemic, this authoritarian country has reported zero cases of covid-19.

Ironically, North Korea, also known as the Democratic People’s Republic of Korea (DPRK) under the leadership of the Kim Jong-un dictator, obtained the Sinovac vaccine through an international cooperative effort called Covax, which distributes covid- to low-income countries. 19 Vaccines.

“The Ministry of Public Health (MOPH) of North Korea has stated that given the limited global supply of COVID-19 vaccines and the repeated surge in certain countries, the 2.97 million doses of vaccine provided by COVAX to North Korea may be transferred to severely affected countries,” UNICEF The spokesperson told Voice of America.

Although North Korea claims that it only wants other countries to obtain the vaccine first, its motive is almost certainly not Altruism, and some experts speculate that the country is rejecting Konoshine because it supports one of the three major brands currently available in the United States-Pfizer, Moderna, and Johnson & Johnson.

Kexing is a vaccine, but it is far less effective than vaccines developed in the WestAccording to a study published in the American Journal of Medicine, Sinovac has an effective rate of 65.9% against infections. New England Journal of Medicine, Although that was before the Delta variant appeared. In contrast, Pfizer’s infection rate is 76%, and Moderna’s rate is 81%. Mayo Clinic, Although in the follow-up actions of the Delta variant, this effect declined sharply, with Pfizer and Moderna dropping to 42% and 76%, respectively.Other studies show that Pfizer is more effective Against Delta.

Oddly enough, North Korea also rejected the UK’s AstraZeneca doses back to July Concerns about side effects are extremely rare. However, these side effects (thrombosis is the most serious) have caused widespread concern in Australia and other places, and have seriously hindered the promotion of the country’s own vaccines.

In the final analysis, North Korea may not have the technology needed to store Pfizer vaccines, which requires extremely low temperatures for refrigeration.

Leif-Eric Easley, a professor at Ewha Womans University, said: “The Kim regime may want to provide the safest and most effective vaccines to the elite, but managing Pfizer needs to upgrade Pyongyang’s cold chain capabilities. And at least a careful discussion with the United States is required.” In South Korea, told guardian this week.

“this [Johnson & Johnson] Given the portability of the vaccine and the one-time option, this option may also be useful to North Korea,” Easley continued.

Whatever the motivation for North Korea’s refusal to vaccinate, if it chooses not to vaccinate against covid-19 in any form, the country will face a difficult 2022. Because although this country has the ability to block borders like other countries, the virus has an extraordinary way to cross.Ask a country like this Vietnam, new Zealand, with Australia——Three places have done a great job dealing with covid-19 in 2020, but are currently suffering from the shock wave of slow vaccine launch and Delta variants.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *